Zenith Healthcare Limited (ZENITHHE.BO)
INR 5.62
(0.36%)
INR 5.62
(0.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.36 Million | -9.24 Million | 13.17 Million | -14.65 Million | 19.53 Million | -564.04 Thousand |
| Net Income | 2.03 Million | 1.18 Million | 6.06 Million | 5.88 Million | 5.84 Million | 1.65 Million |
| Depreciation & Amortization | 2.09 Million | 2.8 Million | 3.58 Million | 2.5 Million | 2.54 Million | 2.47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.18 Million | -12.91 Million | 5.32 Million | -21.41 Million | 11 Million | -4.36 Million |
| Other non-cash items | -8.61 Million | -316 Thousand | -1.78 Million | -1.61 Million | 126.96 Thousand | -320 Thousand |
| Investing Cash Flow | -1.05 Million | -298 Thousand | -2.29 Million | -1.86 Million | -4.97 Million | -531.07 Thousand |
| Investments in PPE | -1.05 Million | -298 Thousand | -2.38 Million | -1.86 Million | -4.97 Million | -530.65 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 85 Thousand | - | - | - |
| Other Investing Activities | -612.00 | -61.2 Million | -612.00 | -612.00 | -612.00 | -416.00 |
| Financing Cash Flow | - | -298 Thousand | -2.29 Million | -1.86 Million | -200 Thousand | 200 Thousand |
| Debt repayment | - | - | - | - | -200 Thousand | -200 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -298 Thousand | -2.29 Million | -1.86 Million | - | 400 Thousand |
| Accounts receivables | 3 Million | 9.41 Million | -15.65 Million | -6.67 Million | -1.06 Million | 6.23 Million |
| Accounts payables | -3.96 Million | -1.65 Million | -3.04 Million | -1 Million | 8.34 Million | -3.59 Million |
| Inventory | 12.81 Million | 3.6 Million | -3.54 Million | -12.62 Million | 2.98 Million | -7.72 Million |
| Other working capital | 2.33 Million | -24.28 Million | 27.56 Million | -1.11 Million | 744.42 Thousand | 713.21 Thousand |
| Cash at beginning of period | 2.02 Million | 18.99 Million | 7.82 Million | 24.33 Million | 9.98 Million | 10.87 Million |
| Cash at end of period | 25.45 Million | 9.15 Million | 18.69 Million | 7.82 Million | 24.33 Million | 9.98 Million |
| Capital Expenditure | -1.05 Million | -298 Thousand | -2.38 Million | -1.86 Million | -4.97 Million | -530.65 Thousand |
| Effect of forex changes on cash | - | -1000.00 | 2.29 Million | 1.86 Million | - | - |
| Net cash flow / Change in cash | 23.43 Million | -9.84 Million | 10.87 Million | -16.51 Million | 14.35 Million | -895.11 Thousand |
| Free Cash Flow | 16.3 Million | -9.54 Million | 10.79 Million | -16.51 Million | 14.55 Million | -1.09 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.03 Million | 992 Thousand | 1.15 Million | 2.56 Million | 1.18 Million | -2.2 Million |
| Depreciation & Amortization | 2.09 Million | 521 Thousand | 551 Thousand | 517 Thousand | 2.8 Million | 742 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.18 Million | - | - | - | -12.91 Million | - |
| Other non-cash items | -8.61 Million | -471 Thousand | -551 Thousand | -517 Thousand | -316 Thousand | -742 Thousand |
| Investing Cash Flow | -1.05 Million | - | - | - | -298 Thousand | - |
| Investments in PPE | -1.05 Million | - | - | - | -298 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -612.00 | - | - | - | -61.2 Million | - |
| Financing Cash Flow | - | - | - | - | -298 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -298 Thousand | - |
| Accounts receivables | 3 Million | - | - | - | 9.41 Million | - |
| Accounts payables | -3.96 Million | - | - | - | -1.65 Million | - |
| Inventory | 12.81 Million | - | - | - | 3.6 Million | - |
| Other working capital | 2.33 Million | - | - | - | -24.28 Million | - |
| Cash at beginning of period | 2.02 Million | 12.23 Million | 11.07 Million | 2.02 Million | 18.99 Million | 4.23 Million |
| Cash at end of period | 25.45 Million | 13.27 Million | 12.23 Million | 2.56 Million | 9.15 Million | 2.02 Million |
| Capital Expenditure | -1.05 Million | - | - | - | -298 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | 23.43 Million | 1.04 Million | 1.15 Million | 535 Thousand | -9.84 Million | -2.2 Million |
| Free Cash Flow | 16.3 Million | 1.04 Million | 1.15 Million | 2.56 Million | -9.54 Million | -2.2 Million |
TAALENT
GAIL
7718
IFABF
RPOWER
ALC